Aroa Biosurgery Ltd
ASX:ARX

Watchlist Manager
Aroa Biosurgery Ltd Logo
Aroa Biosurgery Ltd
ASX:ARX
Watchlist
Price: 0.655 AUD 0.77% Market Closed
Market Cap: 225.9m AUD
Have any thoughts about
Aroa Biosurgery Ltd?
Write Note

Intrinsic Value

The intrinsic value of one ARX stock under the Base Case scenario is 1.083 AUD. Compared to the current market price of 0.655 AUD, Aroa Biosurgery Ltd is Undervalued by 39%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ARX Intrinsic Value
1.083 AUD
Undervaluation 39%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Aroa Biosurgery Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ARX cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ARX?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Aroa Biosurgery Ltd

Provide an overview of the primary business activities
of Aroa Biosurgery Ltd.

What unique competitive advantages
does Aroa Biosurgery Ltd hold over its rivals?

What risks and challenges
does Aroa Biosurgery Ltd face in the near future?

Has there been any significant insider trading activity
in Aroa Biosurgery Ltd recently?

Summarize the latest earnings call
of Aroa Biosurgery Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Aroa Biosurgery Ltd.

Provide P/S
for Aroa Biosurgery Ltd.

Provide P/E
for Aroa Biosurgery Ltd.

Provide P/OCF
for Aroa Biosurgery Ltd.

Provide P/FCFE
for Aroa Biosurgery Ltd.

Provide P/B
for Aroa Biosurgery Ltd.

Provide EV/S
for Aroa Biosurgery Ltd.

Provide EV/GP
for Aroa Biosurgery Ltd.

Provide EV/EBITDA
for Aroa Biosurgery Ltd.

Provide EV/EBIT
for Aroa Biosurgery Ltd.

Provide EV/OCF
for Aroa Biosurgery Ltd.

Provide EV/FCFF
for Aroa Biosurgery Ltd.

Provide EV/IC
for Aroa Biosurgery Ltd.

Show me price targets
for Aroa Biosurgery Ltd made by professional analysts.

What are the Revenue projections
for Aroa Biosurgery Ltd?

How accurate were the past Revenue estimates
for Aroa Biosurgery Ltd?

What are the Net Income projections
for Aroa Biosurgery Ltd?

How accurate were the past Net Income estimates
for Aroa Biosurgery Ltd?

What are the EPS projections
for Aroa Biosurgery Ltd?

How accurate were the past EPS estimates
for Aroa Biosurgery Ltd?

What are the EBIT projections
for Aroa Biosurgery Ltd?

How accurate were the past EBIT estimates
for Aroa Biosurgery Ltd?

Compare the revenue forecasts
for Aroa Biosurgery Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Aroa Biosurgery Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Aroa Biosurgery Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Aroa Biosurgery Ltd compared to its peers.

Compare the P/E ratios
of Aroa Biosurgery Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Aroa Biosurgery Ltd with its peers.

Analyze the financial leverage
of Aroa Biosurgery Ltd compared to its main competitors.

Show all profitability ratios
for Aroa Biosurgery Ltd.

Provide ROE
for Aroa Biosurgery Ltd.

Provide ROA
for Aroa Biosurgery Ltd.

Provide ROIC
for Aroa Biosurgery Ltd.

Provide ROCE
for Aroa Biosurgery Ltd.

Provide Gross Margin
for Aroa Biosurgery Ltd.

Provide Operating Margin
for Aroa Biosurgery Ltd.

Provide Net Margin
for Aroa Biosurgery Ltd.

Provide FCF Margin
for Aroa Biosurgery Ltd.

Show all solvency ratios
for Aroa Biosurgery Ltd.

Provide D/E Ratio
for Aroa Biosurgery Ltd.

Provide D/A Ratio
for Aroa Biosurgery Ltd.

Provide Interest Coverage Ratio
for Aroa Biosurgery Ltd.

Provide Altman Z-Score Ratio
for Aroa Biosurgery Ltd.

Provide Quick Ratio
for Aroa Biosurgery Ltd.

Provide Current Ratio
for Aroa Biosurgery Ltd.

Provide Cash Ratio
for Aroa Biosurgery Ltd.

What is the historical Revenue growth
over the last 5 years for Aroa Biosurgery Ltd?

What is the historical Net Income growth
over the last 5 years for Aroa Biosurgery Ltd?

What is the current Free Cash Flow
of Aroa Biosurgery Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Aroa Biosurgery Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Aroa Biosurgery Ltd

Balance Sheet Decomposition
Aroa Biosurgery Ltd

Current Assets 69m
Cash & Short-Term Investments 30.2m
Receivables 28.9m
Other Current Assets 9.9m
Non-Current Assets 42m
PP&E 22.2m
Intangibles 19.7m
Other Non-Current Assets 104k
Current Liabilities 9.5m
Accounts Payable 3.7m
Accrued Liabilities 3.7m
Other Current Liabilities 2.1m
Non-Current Liabilities 6.6m
Long-Term Debt 6.4m
Other Non-Current Liabilities 174k
Efficiency

Earnings Waterfall
Aroa Biosurgery Ltd

Revenue
69.1m NZD
Cost of Revenue
-10.1m NZD
Gross Profit
59m NZD
Operating Expenses
-69.6m NZD
Operating Income
-10.7m NZD
Other Expenses
43k NZD
Net Income
-10.6m NZD

Free Cash Flow Analysis
Aroa Biosurgery Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ARX Profitability Score
Profitability Due Diligence

Aroa Biosurgery Ltd's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Exceptional Revenue Growth Forecast
ROIC is Increasing
35/100
Profitability
Score

Aroa Biosurgery Ltd's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

ARX Solvency Score
Solvency Due Diligence

Aroa Biosurgery Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

Aroa Biosurgery Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ARX Price Targets Summary
Aroa Biosurgery Ltd

Wall Street analysts forecast ARX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ARX is 0.951 AUD with a low forecast of 0.72 AUD and a high forecast of 1.103 AUD.

Lowest
Price Target
0.72 AUD
10% Upside
Average
Price Target
0.951 AUD
45% Upside
Highest
Price Target
1.103 AUD
68% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ARX?

Click here to dive deeper.

Dividends

Aroa Biosurgery Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for ARX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ARX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Aroa Biosurgery Ltd Logo
Aroa Biosurgery Ltd

Country

New Zealand

Industry

Biotechnology

Market Cap

225.5m AUD

Dividend Yield

0%

Description

Aroa Biosurgery Ltd. engages in the development of products for wound care and soft tissue regeneration. The firm is engaged in commercializing regenerative tissue substitutes for medical conditions where impaired healing leads to serious consequences for patients. The company designs and manufactures medical products which enable surgeons and clinicians to repair serious tissue injuries. The Company’s solutions include Endoform platform, Wound Care Portfolio and Reinforced Bioscaffolds. The Endoform platform is a building block for developing a range of regenerative tissue substitutes to assist with tissue repair and healing. Its wound care products comprise extracellular matrix to manage acute and chronic wounds. The Reinforced Bioscaffolds combine the biologics and synthetics to address the surgical ventral hernia repair solutions.

Contact

AUCKLAND
64 Richard Pearse Drive, Mangere
+6498693035.0
aroabio.com

IPO

2020-07-24

Employees

-

Officers

Founder, CEO, MD & Executive Director
Dr. Brian Ward B.V.Sc, MBA(dist)
CFO & Joint Company Secretary
Mr. James Agnew BCom, LLB
Chief Technology Officer
Mr. Rod Stanley M.Sc.
Chief Scientific Officer
Dr. Barnaby C.H. May Ph.D.
General Counsel
Ms. Neetha Alex-Kumar
Director of Global Marketing & Strategy
Mr. Frazer Murray
Show More
Vice President of Quality, Regulatory & Sustainability
Ms. Yasmin Winchester B.Sc.
Joint Company Secretary
Ms. Tracy Weimar BA, MBA
Vice President of Medical Affairs
Mr. Adam Young Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one ARX stock?

The intrinsic value of one ARX stock under the Base Case scenario is 1.083 AUD.

Is ARX stock undervalued or overvalued?

Compared to the current market price of 0.655 AUD, Aroa Biosurgery Ltd is Undervalued by 39%.

Back to Top